Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
Public ClinicalTrials.gov record NCT00333151. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Effect on Glycemic Control of Liraglutide in Combination With Rosiglitazone Plus Metformin Versus Rosiglitazone Plus Metformin in Subjects With Type 2 Diabetes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This trial is conducted in the United States of America (USA) and Canada. This trial is designed to show the effect of treatment with liraglutide when added to existing rosiglitazone and metformin combination therapy and to compare it with the effects of therapy with rosiglitazone and metformin alone.
Study identification
- NCT ID
- NCT00333151
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 576 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2006 (Type not available)
- Primary completion
- Aug 2007 (Actual)
- Completion
- Aug 2007 (Actual)
- Last update posted
- Jan 25, 2017
2006 – 2007
United States locations
- U.S. sites
- 71
- U.S. states
- 28
- U.S. cities
- 62
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novo Nordisk Investigational Site | Goodyear | Arizona | 85395 | — |
| Novo Nordisk Investigational Site | Colton | California | 92324 | — |
| Novo Nordisk Investigational Site | Concord | California | 94520 | — |
| Novo Nordisk Investigational Site | Escondido | California | 92025 | — |
| Novo Nordisk Investigational Site | La Jolla | California | 92037 | — |
| Novo Nordisk Investigational Site | Long Beach | California | 90822 | — |
| Novo Nordisk Investigational Site | Los Angeles | California | 90024 | — |
| Novo Nordisk Investigational Site | Los Angeles | California | 90057 | — |
| Novo Nordisk Investigational Site | Mission Viejo | California | 92691 | — |
| Novo Nordisk Investigational Site | Orange | California | 92869 | — |
| Novo Nordisk Investigational Site | Santa Ana | California | 92705 | — |
| Novo Nordisk Investigational Site | Santa Barbara | California | 93105 | — |
| Novo Nordisk Investigational Site | Spring Valley | California | 91978 | — |
| Novo Nordisk Investigational Site | New Britain | Connecticut | 06050 | — |
| Novo Nordisk Investigational Site | Washington D.C. | District of Columbia | 20010 | — |
| Novo Nordisk Investigational Site | Fort Myers | Florida | 33907 | — |
| Novo Nordisk Investigational Site | Jacksonville | Florida | 32204 | — |
| Novo Nordisk Investigational Site | Lake Mary | Florida | 32746 | — |
| Novo Nordisk Investigational Site | Plantation | Florida | 33324 | — |
| Novo Nordisk Investigational Site | Athens | Georgia | 30606 | — |
| Novo Nordisk Investigational Site | Atlanta | Georgia | 30032 | — |
| Novo Nordisk Investigational Site | Atlanta | Georgia | 30034 | — |
| Novo Nordisk Investigational Site | Atlanta | Georgia | 30318 | — |
| Novo Nordisk Investigational Site | Powder Springs | Georgia | 30127 | — |
| Novo Nordisk Investigational Site | Idaho Falls | Idaho | 83404-7596 | — |
| Novo Nordisk Investigational Site | Peoria | Illinois | 61615 | — |
| Novo Nordisk Investigational Site | New Albany | Indiana | 47150 | — |
| Novo Nordisk Investigational Site | Des Moines | Iowa | 50314 | — |
| Novo Nordisk Investigational Site | Topeka | Kansas | 66606 | — |
| Novo Nordisk Investigational Site | Lexington | Kentucky | 40503 | — |
| Novo Nordisk Investigational Site | Baton Rouge | Louisiana | 70808 | — |
| Novo Nordisk Investigational Site | New Orleans | Louisiana | 70121 | — |
| Novo Nordisk Investigational Site | Hyattsville | Maryland | 20782 | — |
| Novo Nordisk Investigational Site | Tupelo | Mississippi | 38801 | — |
| Novo Nordisk Investigational Site | St Louis | Missouri | 63110 | — |
| Novo Nordisk Investigational Site | Reno | Nevada | 89502 | — |
| Novo Nordisk Investigational Site | Berlin | New Jersey | 08009 | — |
| Novo Nordisk Investigational Site | Plainsboro | New Jersey | 08536 | — |
| Novo Nordisk Investigational Site | Albany | New York | 12206 | — |
| Novo Nordisk Investigational Site | Brooklyn | New York | 11203 | — |
| Novo Nordisk Investigational Site | Northport | New York | 11768 | — |
| Novo Nordisk Investigational Site | Rochester | New York | 14621 | — |
| Novo Nordisk Investigational Site | Asheville | North Carolina | 28803 | — |
| Novo Nordisk Investigational Site | Chapel Hill | North Carolina | 27599-7172 | — |
| Novo Nordisk Investigational Site | Durham | North Carolina | 27710 | — |
| Novo Nordisk Investigational Site | Greenville | North Carolina | 27834 | — |
| Novo Nordisk Investigational Site | Cincinnati | Ohio | 45245 | — |
| Novo Nordisk Investigational Site | Cleveland | Ohio | 44195 | — |
| Novo Nordisk Investigational Site | Columbus | Ohio | 43203 | — |
| Novo Nordisk Investigational Site | Columbus | Ohio | 43212 | — |
| Novo Nordisk Investigational Site | Dayton | Ohio | 45406 | — |
| Novo Nordisk Investigational Site | Kettering | Ohio | 45429 | — |
| Novo Nordisk Investigational Site | Mentor | Ohio | 44060 | — |
| Novo Nordisk Investigational Site | Duncan | South Carolina | 29334 | — |
| Novo Nordisk Investigational Site | Chattanooga | Tennessee | 37404 | — |
| Novo Nordisk Investigational Site | Arlington | Texas | 76014 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75230 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75231 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75246 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75390-8858 | — |
| Novo Nordisk Investigational Site | Houston | Texas | 77025 | — |
| Novo Nordisk Investigational Site | Houston | Texas | 77030 | — |
| Novo Nordisk Investigational Site | Lubbock | Texas | 79430-8183 | — |
| Novo Nordisk Investigational Site | Midland | Texas | 79707 | — |
| Novo Nordisk Investigational Site | San Antonio | Texas | 78209 | — |
| Novo Nordisk Investigational Site | San Antonio | Texas | 78229 | — |
| Novo Nordisk Investigational Site | Salt Lake City | Utah | 84102 | — |
| Novo Nordisk Investigational Site | Newport News | Virginia | 23606 | — |
| Novo Nordisk Investigational Site | Richmond | Virginia | 23294 | — |
| Novo Nordisk Investigational Site | Spokane | Washington | 99218 | — |
| Novo Nordisk Investigational Site | Milwaukee | Wisconsin | 53209 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00333151, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 25, 2017 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00333151 live on ClinicalTrials.gov.